LifeCodexx AG
LifeCodexx AG, headquartered in Germany, is a pioneering company in the field of molecular diagnostics, specialising in non-invasive prenatal testing (NIPT). Founded in 2012, LifeCodexx has established itself as a leader in genetic testing, offering innovative solutions that empower expectant parents with critical information about their unborn child's health. The company’s flagship product, the LifeCodexx NIPT, stands out for its accuracy and reliability, utilising advanced genomic technologies to analyse cell-free DNA from maternal blood. With a commitment to quality and precision, LifeCodexx AG has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence across Europe and beyond. Recognised for its contributions to prenatal care, LifeCodexx AG continues to shape the future of genetic testing, ensuring that families receive the best possible insights into their health and wellbeing.
DitchCarbon Score
How does LifeCodexx AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LifeCodexx AG's score of 75 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LifeCodexx AG, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Eurofins Scientific SE, which may influence its climate commitments and reporting practices. While LifeCodexx AG has not established its own reduction targets or climate pledges, it is important to note that it inherits sustainability initiatives from Eurofins Scientific SE. This includes potential commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded from Eurofins Scientific SE at a cascade level of 2. As a part of the broader Eurofins Scientific SE corporate family, LifeCodexx AG may align its climate strategies with the parent company's objectives, although specific targets and achievements for LifeCodexx AG itself remain unspecified. The company is expected to adhere to industry standards in climate action, reflecting the growing emphasis on sustainability within the life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 72,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 155,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 311,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
LifeCodexx AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
